The partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m
With the combination of oral solid, inhalation, dermatology, high potent and oral contraceptive products, this is an important facility of the company
The new powder flow tester can characterize powder flow properties, offering valuable insight for pharmaceutical processing and formulation
The estimated national burden of asthma in India is at 17.23 million with an overall prevalence of 2.05% and out of this, approximately 30 lakh patients can be classified under “inadequately controlled”
Cipla and Ethris partner for the development of mRNA-based therapies
The joint venture will help both the parties to further develop the high-margin service business
This clinical study will inform operational logistics and use of AV7909 should an anthrax emergency occur.
Lutio has the potential to offer significant cost savings when available to UK patients.
Moderna continues to expand its mRNA platform for a range of additional clinical applications and routes of administration including a modality for lung delivery
This ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies
Subscribe To Our Newsletter & Stay Updated
